Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (250)	12/9/2005 10:59:33 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 684

Well, there had been very good support of DPII at $3, and I bought it just above that. If Pfizer had renewed, I'd have got a nice little pop out of that, but instead the other shoe dropped. Now there seems to be no rush to get in--but this is certainly the time of year to put together a positon. Large blocks (who knows, maybe the ex-CEO) go off periodically around $2.35--so that is a great price to pay. Most of those shares are probably being sucked up by one of the microcap value funds--or maybe the company itself. I don't think they can work their book value down much more--and they cannot really burn through very much cash, if this does a Cadus they'll still have something around $70m a year from now. But I don't think it will do that, they have some business still and the small molecule library repository thing for the NIH. And it wont last that long. I beleive I will own a PCOP or a Discoverx or another little company that will IPO through these free shares. I hope that happens, it is the only out I have now. I don't want to take the loss! I see your other charts--I don't think Xcyte has enough cash to do anything with. I did not buy Corgentech (or whatever it is) becasue I figured there were hobbled by having a drug. DPII was the biggest thing I could find that traded for as much of a discount to book value--and cash and book were reasonably close, they seem to be making a big effort to make the balance sheet so clean even I can read it.